SONN icon

Sonnet BioTherapeutics
SONN

Overview Fund Trends Analyst Outlook Journalist POV

10 hedge funds and large institutions have $550K invested in Sonnet BioTherapeutics in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$255K
2
+$223K
3
+$20.7K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$15.7K
5
TRCT
Tower Research Capital (TRC)
New York
+$4.17K

Top Sellers

1
-$64.1K
2
-$71
3
-$41
4
PWMG
Private Wealth Management Group
New Jersey
-$6
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$255K
2
$223K
3
$31K
4
$15.7K
5
$13.8K
6
$6.73K
7
$3.75K
8
$488
9
$27
10
$4
11
$3
12
–
13
–
14
–